Global Large Volume Intravenous Solution Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Large Volume Intravenous Solution Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs.
Large Volume Intravenous Solution report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Large Volume Intravenous Solution market is projected to reach US$ 3354.8 million in 2029, increasing from US$ 2253 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Basic IV Solutions and Nutrient Infusion Solution are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Large Volume Intravenous Solution industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Large Volume Intravenous Solution key manufacturers include Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, B. Braun Melsungen, JW Life Science and Grifols, etc. Baxter, Kelun Group, Fresenius Kabi are top 3 players and held % sales share in total in 2022.
Large Volume Intravenous Solution can be divided into Crystalloids, Colloids and Others,, etc. Crystalloids is the mainstream product in the market, accounting for % sales share globally in 2022.
Large Volume Intravenous Solution is widely used in various fields, such as Basic IV Solutions, Nutrient Infusion Solution and Others,, etc. Basic IV Solutions provides greatest supports to the Large Volume Intravenous Solution industry development. In 2022, global % sales of Large Volume Intravenous Solution went into Basic IV Solutions filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Large Volume Intravenous Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
B. Braun Melsungen
JW Life Science
Grifols
Segment by Type
Crystalloids
Colloids
Others
Basic IV Solutions
Nutrient Infusion Solution
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Large Volume Intravenous Solution market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Large Volume Intravenous Solution, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Large Volume Intravenous Solution industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Large Volume Intravenous Solution in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Large Volume Intravenous Solution introduction, etc. Large Volume Intravenous Solution Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Large Volume Intravenous Solution market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Large Volume Intravenous Solution report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Large Volume Intravenous Solution market is projected to reach US$ 3354.8 million in 2029, increasing from US$ 2253 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Basic IV Solutions and Nutrient Infusion Solution are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Large Volume Intravenous Solution industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Large Volume Intravenous Solution key manufacturers include Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, B. Braun Melsungen, JW Life Science and Grifols, etc. Baxter, Kelun Group, Fresenius Kabi are top 3 players and held % sales share in total in 2022.
Large Volume Intravenous Solution can be divided into Crystalloids, Colloids and Others,, etc. Crystalloids is the mainstream product in the market, accounting for % sales share globally in 2022.
Large Volume Intravenous Solution is widely used in various fields, such as Basic IV Solutions, Nutrient Infusion Solution and Others,, etc. Basic IV Solutions provides greatest supports to the Large Volume Intravenous Solution industry development. In 2022, global % sales of Large Volume Intravenous Solution went into Basic IV Solutions filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Large Volume Intravenous Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
B. Braun Melsungen
JW Life Science
Grifols
Segment by Type
Crystalloids
Colloids
Others
Segment by Application
Basic IV Solutions
Nutrient Infusion Solution
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Large Volume Intravenous Solution market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Large Volume Intravenous Solution, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Large Volume Intravenous Solution industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Large Volume Intravenous Solution in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Large Volume Intravenous Solution introduction, etc. Large Volume Intravenous Solution Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Large Volume Intravenous Solution market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
